Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025

Core Insights - Avantor Inc reported fourth-quarter net sales of $1.69 billion, a 2$1.71 billion [1] - The company experienced a net income increase to $500.4 million from$98.5 million a year ago, with adjusted net income at $183.9 million compared to$166.7 million in the prior period [1][2] - Adjusted EBITDA was reported at $307.7 million with a margin of 18.2$279.4 million with a margin of 16.6% [2] - The adjusted EPS was 27 cents, slightly down from 29 cents a year ago, but beating the consensus of 26 cents [2] - Operating cash flow was $173.3 million, and free cash flow was$222.1 million [2] Sales Performance - Laboratory Solutions' net sales were $1.13 billion, down 5$560.8 million, up 4%, with a 4% organic sales increase [4] Future Guidance - Avantor expects organic revenue growth of 1%-3% in 2025 compared to a 2% decline in 2024, with an adjusted EBITDA margin of 18%-19% [4] - The company forecasts adjusted EPS of $1.02-$1.10 versus the consensus of $1.10 and expected free cash flow of$650 million to $700 million [4] Market Reaction - AVTR stock is down 3.73$20.89 during the premarket session [5]